Exelixis
EXEL
#1566
Rank
โ‚ฌ10.30 B
Marketcap
36,69ย โ‚ฌ
Share price
0.13%
Change (1 day)
76.43%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company